LLNL-Led Study Uses Machine Learning, Veterans' Health Records to Identify ALS Drug Repurposing Candidates
· lawrence livermore national laboratory
AI Briefing
- LLNL-led study identifies potential ALS drug repurposing candidates using machine learning and veterans' health records.
- Researchers found several existing medications that may be associated with longer survival in people with ALS.
- The study's findings could lead to new avenues for treating the incurable neurological disease.
Advertisement